Is FOMO Entering the Private Equity Dynamic?
- kshepherd72
- Apr 14, 2022
- 1 min read
Orthopedics and podiatry are a highly fragmented market, making for a unique consolidation opportunity for private equity (PE). Growth is easy to measure with a total of eight PE firms that invested in orthopedic group platforms in 2020, and now there are 14 PE-backed orthopedic platforms focused on the musculoskeletal segment.
Earnings before interest, taxes, depreciation and amortization (EBIDTA)
EBIDTA, a common way to measure net profitability of a company, is a tool to value transactions that involve forward projections. A PE deal involves paying now for future income. This deal is expressed in a multiple of EBIDTA: EBIDTA x EBIDTA Multiple = Valuation.
Orthopedic and podiatry multiples differ
The strong demand is creating intense competition among private equity firms, hospitals, and strategic healthcare companies for orthopedic practices, leading to higher valuations. Current ranges for podiatry practices are 4% to 8% and 6% to 14% for orthopedic practices.
Recent Posts
See AllThe ongoing consolidation in the foot and ankle market is progressing steadily. In a January 28 company report , Zimmer Biomet (ZB)...
The " Same Rate for Same Service" concept argues that services should be paid equally, regardless of where they are provided. This...
For years, the emphasis on focal cartilage lesions has been primarily on restoring the cartilage cap. However, evolving knowledge...
Comments